Stepan Just Raised Its Dividend for the 59th Straight Year. Most Investors Have Never Heard of It

Stepan Company (NYSE:SCL) raised its quarterly dividend to $0.405 per share, marking 59 consecutive years of increases. The company, valued at $1.48 billion, supplies surfactants and polymers. Q3 2026 revenue was $692.15 million, with adjusted EPS of $0.94. Stepan's dividend yield is 2.4%, with a payout ratio of 23.7% of operating cash flow. The stock is up 43.25% in 2026 but down 38.58% over five years.

Original reporting
Published Oct 28, 2026, 2:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 2:18 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Stepan Just Raised Its Dividend for the 59th Straight Year. Most Investors Have Never Heard of It — source image
Decision brief

The 30-second read

$SCLBullishMed
01

Why it matters

The dividend increase reinforces its Dividend King status, potentially supporting the stock price amid broader market volatility.

02

Market read

Income investors may add SCL for its reliable dividend growth; modest price impact expected.

03

What to watch

Raw material cost volatility could pressure margins, potentially limiting future dividend growth.

Relevance 6/10Novelty 7/10Timing: after-market today

Background

Stepan is a specialty chemicals maker focused on surfactants and polymers, with a history of consistent dividend growth.

Company-level read

Ticker impact

$SCLBullishHigh confidence
Context

Stepan Company announced a quarterly dividend increase to $0.405 per share, its 59th consecutive raise, marking a new 2.4% yield.

Expected impact

likely modest upward pressure as yield improves

Evidence & confidence

The new dividend and yield are fresh data, and income investors typically respond positively to dividend raises, especially for a Dividend King.

Market effects

Highlights strength of specialty chemicals sector's cash flow and dividend reliability.

US small-cap dividend stocks may see modest inflows.

Limited to investors tracking dividend aristocrats worldwide.

Counterpoint

Yield remains modest at ~2.4% and price volatility is high; investors may prefer higher-yield alternatives.

Key entities

  • Stepan Company

    Specialty chemicals producer and Dividend King.

Related articles

$SCLMed

Stepan Co (SCL) (Q3 2026) Earnings Call Highlights: 7% Organic Volume Growth

Stepan Co (SCL) reported Q3 2026 earnings with 7% organic volume growth and 18% year-over-year adjusted EBITDA increase to $66.3M. Project Catalyst savings exceeded targets, and net leverage improved. Dividends increased for the 59th consecutive year. Challenges include weak polymer volumes in Europe and Asia, rising raw material costs, and a regulatory maintenance turnaround in Germany.

$SCLHighAI 8/10

Stepan (SCL) Q3 2026 Earnings Call Transcript

Stepan (SCL) reported Q3 2026 earnings with adjusted EBITDA up 18% YoY to $66.3M, driven by volume growth and margin recovery. Net income rose 64% to $17.8M. Sales increased across surfactants, polymers, and specialty products. Project Catalyst savings exceeded expectations. Management cited geopolitical risks and rising raw material costs as challenges.

$SCLMedAI 8/10

Stepan Company Q3 2026 Earnings Call Summary

Stepan Company reported Q3 2026 earnings with 7% organic volume growth, driven by North American polymers and surfactants. Margin recovery was sustained through pricing actions and cost offsets. Project Catalyst savings reached $23M quarterly, with expectations to exceed $25M in 2027. The company anticipates full-year 2026 adjusted EBITDA growth, positive free cash flow, and balance sheet deleveraging. Net leverage improved to 2.4x from 2.7x year-over-year.

$SCLMed

Stepan Q3 Earnings Call Highlights

Stepan Company (NYSE: SCL) reported Q3 net sales up 12% to $27M, with adjusted EBITDA rising 5% to $11.7M. Management cited higher volume in MCT products and cost pressures from volatile oil markets. Project Catalyst savings exceeded expectations, with $23M quarterly savings and $66M-$70M expected for 2026. Net debt reduced to $536M, and the dividend was raised by 2.5%.

$SCLMedAI 8/10

Stepan Q3 2026 slides: EPS doubles on volume growth, restructuring

Stepan Company (SCL) reported Q3 2026 adjusted EPS of $0.94, up 98% YoY, driven by 7% volume growth and restructuring savings. Revenue and EPS beat estimates. Shares rose 2.42%. Adjusted EBITDA increased 18% to $66.3M. Project Catalyst restructuring is ahead of schedule, with $23M quarterly savings. Net leverage ratio improved to 2.4x. Free cash flow was $8M, impacted by working capital build.